Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Return on Sales (2022 - 2025)

Arcutis Biotherapeutics has reported Return on Sales over the past 4 years, most recently at 0.14% for Q4 2025.

  • Quarterly results put Return on Sales at 0.14% for Q4 2025, up 29.0% from a year ago — trailing twelve months through Dec 2025 was 0.04% (up 68.0% YoY), and the annual figure for FY2025 was 0.04%, up 80.0%.
  • Return on Sales for Q4 2025 was 0.14% at Arcutis Biotherapeutics, up from 0.07% in the prior quarter.
  • Over the last five years, Return on Sales for ARQT hit a ceiling of 0.14% in Q4 2025 and a floor of 148.56% in Q3 2022.
  • Median Return on Sales over the past 4 years was 1.21% (2023), compared with a mean of 16.12%.
  • Biggest five-year swings in Return on Sales: skyrocketed 14707bps in 2023 and later rose 29bps in 2025.
  • Arcutis Biotherapeutics' Return on Sales stood at 24.32% in 2022, then skyrocketed by 80bps to 4.9% in 2023, then soared by 97bps to 0.16% in 2024, then soared by 189bps to 0.14% in 2025.
  • The last three reported values for Return on Sales were 0.14% (Q4 2025), 0.07% (Q3 2025), and 0.19% (Q2 2025) per Business Quant data.